3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Refractory/Relapse Neuroblastoma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Neuroendocrine Tumors
1
Neoplasms, Squamous Cell
1
Neoplasms
1
Nasopharyngeal Carcinoma
1
Lymphoma
1
Lung Neoplasms
1
Hysterectomies for Low- or Intermediate-risk Endometrial Carcinoma
1
Esophageal Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Breast Neoplasms
1
Interventions
Cyclophosphamide
8
ibrutinib
5
fludarabine phosphate
5
fludarabine
5
pirtobrutinib
4
obinutuzumab
4
acalabrutinib
4
Mesna
4
venetoclax
3
Mycophenolic Acid
3
Melphalan
3
Whole-Body Irradiation
2
Tacrolimus
2
Rituximab
2
Peripheral Blood Stem Cell Transplantation
2
Patient Reported Outcome Measures
2
Busulfan
2
Bone Marrow Transplantation
2
ARQ531
2
zanubrutinib
1
ricolinostat
1
idelalisib
1
idecabtagene vicleucel
1
Vincristine
1
Stem Cell Transplantation
1
Rabeprazole
1
Prednisone
1
Leukapheresis
1
Itraconazole
1
Filgrastim
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia, B-Cell
×
Biological Products
×
1 year
×
Clear all
No trials found.